Insights

Strategic Use of Evidence at the Patent Trial and Appeal Board

Hatch-Waxman 2023 Year in Review

Legal Alert: FTC Challenges More Than 100 Patents as Improperly Listed in Orange Book

District of Delaware Finds Allergan Patents Invalid for Lack of Written Description and Obviousness-Type Double Patenting in Allergan v. MSN Labs

Minnesota Patent Litigation Wrap-Up: Q3 2023

ITC Monthly Wrap-Up: October 2023

Texas Patent Litigation Monthly Wrap-Up: October 2023